Scientists have long believed that a newborn's immune system was an immature version of an adult's, but new research from Cornell University shows that newborns' T cells—white blood cells that protect from disease—outperform ...
Feb 23, 2024
0
28
Although it is one of the oldest medications used to treat patients with inflammatory bowel disease (IBD) and an effective treatment for an associated arthritis condition called spondyloarthritis (SpA), sulfasalazine's mechanism ...
Feb 20, 2024
0
36
Research involving animal models—for purposes such as developing new vaccines or regenerative medicines—generally employs mice, but new Cornell research has identified another species that could be valuable to supplement ...
Feb 13, 2024
0
0
An experimental mRNA vaccine against human cytomegalovirus (CMV), a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any CMV vaccine candidate, according ...
Feb 9, 2024
0
22
Malnutrition of Indian children rose dramatically during the COVID-19 pandemic, according to new research from the Tata-Cornell Institute for Agriculture and Nutrition (TCI).
Feb 5, 2024
0
0
Patients with an appearance-altering skin condition may have relief thanks to an unlikely cocktail of a molecule that induces labor, an immunosuppressant medication and controlled UVB irradiation.
Feb 1, 2024
0
28
An interdisciplinary collaboration has used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice.
Jan 23, 2024
0
71
Getting tobacco vaping warning labels right for both adults and teens has proven complex, as regulators confront two public health challenges: How to promote e-cigarette use as an alternative for adults who smoke cigarettes, ...
Jan 22, 2024
0
1
Cornell researchers have taken an important step toward harnessing CRISPR gene editing in "targeted, safe and potent" cancer treatment, according to Ailong Ke, professor of chemistry and chemical biology in the College of ...
Jan 22, 2024
0
0
Cornell researchers have created a genetically engineered mouse model that could shed light on the causes of human infertility and allow researchers to explore other areas of reproduction.
Jan 18, 2024
0
0
